Repligen
RGEN
#2596
Rank
S$8.24 B
Marketcap
S$146.31
Share price
0.39%
Change (1 day)
-28.20%
Change (1 year)
Categories

Earnings for Repligen (RGEN)

Earnings in 2025 (TTM): S$31.68 Million

According to Repligen 's latest financial reports the company's current earnings are S$0.70 Billion. In 2024 the company made an earning of -S$8.08 Million a decrease over its 2023 earnings that were of S$62.07 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Repligen from 1985 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) S$31.68 M-492.26%
2024 -S$8.08 Million-113.01%
2023 S$62.07 M-78.01%
2022 S$0.28 B33.37%
2021 S$0.21 B131.52%
2020 S$91.4 M101.31%
2019 S$45.4 M25.93%
2018 S$36.05 M105.61%
2017 S$17.53 M-11.46%
2016 S$19.8 M14.91%
2015 S$17.23 M20.26%
2014 S$14.33 M-51.49%
2013 S$29.54 M90.98%
2012 S$15.47 M
2010 S$0.22 M-103.81%
2009 -S$5.88 Million-223.84%
2008 S$4.74 M
2006 -S$3.19 Million229.64%
2005 -S$0.97 Million-89.16%
2004 -S$8.93 Million-16.86%
2003 -S$10.74 Million88.72%
2002 -S$5.69 Million-27.88%
2001 -S$7.89 Million-1.74%
2000 -S$8.03 Million85.93%
1999 -S$4.32 Million159.16%
1998 -S$1.67 Million85.71%
1997 -S$0.9 Million-70.83%
1996 -S$3.08 Million-72.41%
1995 -S$11.15 Million-60.63%
1994 -S$28.32 Million45.39%
1993 -S$19.48 Million39.45%
1992 -S$13.97 Million-32.3%
1991 -S$20.63 Million6.62%
1990 -S$19.35 Million1577.78%
1989 -S$1.16 Million-57.14%
1988 -S$2.7 Million-362.5%
1987 S$1.02 M-130.77%
1986 -S$3.34 Million136.36%
1985 -S$1.41 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
S$15.18 B 45,237.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
S$9.09 B 27,044.06%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
S$13.89 B 41,377.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$10.29 B 30,628.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
-S$0.14 Billion-517.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
S$0.48 B 1,334.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
S$0.74 B 2,130.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
S$0.15 B 372.34%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
S$0.87 B 2,498.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Charles River Laboratories
CRL
-S$28.44 Million-184.90%๐Ÿ‡บ๐Ÿ‡ธ USA